Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

In a longitudinal study of HIV seropositive patients, there were fluctuations in the specificity of cytotoxic T cells for the virus. This was matched by variability in proviral gag DNA epitope sequences in the lymphocytes of these patients. Some of these viral variants are not recognized by autologous T cells. Accumulation of such mutations in T-cell antigenic targets would provide a mechanism for immune escape.

[1]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[2]  P. Simmonds,et al.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.

[3]  J. Phair,et al.  A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.

[4]  B. Autran,et al.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. , 1989, Journal of immunology.

[5]  B. Walker,et al.  HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.

[6]  J. Berzofsky,et al.  A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. , 1989, Science.

[7]  Wei-Shau Hu,et al.  Retroviral recombination and reverse transcription. , 1990, Science.

[8]  D. Nixon,et al.  Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. , 1990, International immunology.

[9]  A. Meyerhans,et al.  In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.

[10]  G. Shearer,et al.  Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. , 1984, The Journal of clinical investigation.

[11]  J. Berzofsky,et al.  An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Bolognesi.  HIV antibodies and vaccine design , 1989, AIDS.

[13]  C H Fox,et al.  The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.

[14]  D. Nixon,et al.  High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. , 1990, International immunology.

[15]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[16]  B. Moss,et al.  CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Pearl,et al.  Characterization of HIV‐1 neutralization escape mutants , 1989, AIDS.

[18]  G. Gaudernack,et al.  CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. , 1990, Journal of immunology.

[19]  An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. , 1990, AIDS.

[20]  R. Koup,et al.  Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. , 1989, Blood.

[21]  B. Autran,et al.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. , 1989, Journal of immunology.

[22]  B. Autran,et al.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.

[23]  P. Simmonds,et al.  HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.

[24]  D. Glover.  DNA cloning : a practical approach , 1985 .

[25]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[26]  M. Reitz,et al.  Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene , 1988, Cell.

[27]  R. Gallo,et al.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Parham,et al.  CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[29]  Gilcher Ro.  Human retroviruses and AIDS. , 1988 .

[30]  D. Nixon,et al.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.

[31]  R. Tedder,et al.  HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN TWO COHORTS OF HOMOSEXUAL MEN: NEUTRALISING SERA AND ASSOCIATION OF ANTI-GAG ANTIBODY WITH PROGNOSIS , 1987, The Lancet.

[32]  J. McCune,et al.  HIV-1: The infective process in vivo , 1991, Cell.

[33]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[34]  U. Koszinowski,et al.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.

[35]  M A Nowak,et al.  The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. , 1990, AIDS.

[36]  J. Rothbard,et al.  Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes , 1987, The Journal of experimental medicine.

[37]  B. Walker,et al.  HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.

[38]  D. Watkins,et al.  A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. , 1989, Disease markers.

[39]  J. Levy,et al.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.

[40]  P. Earl,et al.  Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. , 1988, Proceedings of the National Academy of Sciences of the United States of America.